報價延遲最少15分鐘:2026/09/01 07:59 EDT
盤前時段
|
||||
|
2.31 
|
|
|
常規時段 (已結束)
|
|
|
|
|
||||||||||||
|
|
|
|
|
2.25
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.16/-0.20
|
|
企業價值
1.08B
|
| 資產負債 |
|
每股賬面淨值
0.39
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
49.80M
|
|
每股收益
0.00
|
|
同行比較
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic. |
